<DOC>
	<DOCNO>NCT02466217</DOCNO>
	<brief_summary>The family inflammatory/autoimmune systemic disease ( IAD ) form continuum pure inflammatory diseases pure autoimmune disease , encompass large panel inflammatory disease autoimmune component , vice versa . Cross phenotyping patient IAD heuristic help revise nosography understanding disease .</brief_summary>
	<brief_title>Phenomics Autoimmune Inflammatory Diseases</brief_title>
	<detailed_description>The family inflammatory/autoimmune systemic disease ( IAD ) represent large group human diseases . For IAD , pathophysiological process exact cause remain poorly understood . Progresses molecular understand IAD lead realize two distinct category diseases . Rather form continuum pure inflammatory diseases pure autoimmune disease , encompass large panel inflammatory disease autoimmune component , vice versa . Using system biology , investigator aim improve understand disease , identify novel genes/pathways involve , specific across disease , discover biomarkers potential therapeutic target . The investigator study adult patient least one follow IAD : Rheumatoid Arthritis , Ankylosing Spondylitis , Systemic Lupus Erythematosus/Antiphospholipid Syndrome , Familial Mediterranean Fever ( FMF ) , Cryopyrin-Associated Periodic Syndromes ( CAPS ) /Tumor Necrosis Factor-receptor Associated Periodic Syndrome ( TRAPS ) , Vasculitis , Uveitis , Myositis , Crohn 's Disease , Ulcerative colitis , Type 1 Diabetes . This panel complete control group : healthy volunteer , patient arthritis ( knee and/or hip ) muscular dystrophy . The biological investigation notably comprise : immunomics ( comprehensive evaluation peripheral blood cell subset serum immunoproteomics , include autoantibody ) ; transcriptomics ; Human Leukocyte Antigen ( HLA ) -phenotyping ; genomics ; T-Cell Receptor ( TCR ) sequence microbiota study . After sign informed consent , subject attend one visit ( Day 0 ) biological sample take clinical information collect .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Myositis</mesh_term>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Cryopyrin-Associated Periodic Syndromes</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Hereditary Autoinflammatory Diseases</mesh_term>
	<mesh_term>Proctocolitis</mesh_term>
	<criteria>Presenting either : one IAD list ( Rheumatoid Arthritis , Ankylosing Spondylitis , Systemic Lupus Erythematosus/Antiphospholipid Syndrome , FMF , CryopyrinAssociated Periodic Syndromes ( CAPS ) /Tumor Necrosis Factor ( TNF ) receptor Associated Periodic Syndrome , Vasculitis , Uveitis , Myositis , Crohn 's Disease , Ulcerative colitis , Type 1 Diabetes ) unclassified IAD : knee and/or hip arthritis muscular dystrophy healthy subject Good vein Affiliation social security system Informed consent form , sign participant investigator , prior need examination For IADs patient Unauthorized treatment ( anticancer chemotherapy ) For Healthy volunteer Contraindications donate blood except age Known history IAD ( eg : Psoriasis ) Common exclusion criterion : Pregnant woman Still exclusion period another biomedical study Psychiatric addiction pathology could interfere ability fulfill protocol need provide inform consent Patient legal protection Chronic lifelong viral infection unrelated pathology Mild infection within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Auto-immune disease</keyword>
	<keyword>Auto-inflammatory disease</keyword>
	<keyword>Omics</keyword>
	<keyword>System biology</keyword>
</DOC>